A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.
about
A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@en
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@nl
type
label
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@en
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@nl
prefLabel
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@en
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@nl
P2093
P2860
P356
P1476
A Jehovah's Witness with Acute ...... ng Minimum Blood Transfusions.
@en
P2093
Akihito Kawashima
Eri Kashiwagi
Yumi Yamamoto
P2860
P304
P356
10.1155/2014/141260
P577
2014-10-02T00:00:00Z